Grand Challenges Africa: call for proposals for drug discovery

Now closed

New funding to develop the capacity of African scientists 

The African Academy of Sciences (AAS), University of Cape Town (UCT) Drug Discovery and Development Centre (H3D), Medicines for Malaria Venture (MMV) and the Bill & Melinda Gates Foundation have committed funding for the discovery of new drugs for diseases endemic to Africa over the next two years. 

The new funding will be given through a call for proposals for Drug Discovery offering up to $100,000 per project to researchers in Africa to identify new drug candidates, particularly for malaria, tuberculosis and neglected tropical diseases and to create a network of drug discovery and development scientists that will initiate, develop, share, evaluate and disseminate best approaches and practices within the research community in Africa.   

This is the third call for proposals administered by the AAS’ Grand Challenges Africa (GC Africa), a scheme implemented through the AAS and the NEPAD Agency’s Alliance for Accelerating Excellence in Science in Africa (AESA). 

Further information about the Drug Discovery call for proposals: 

  • Applicants are required to submit a letter of interest by 18 July 2018, which will determine if the AAS and partners will invite them to submit full proposals. Successful applicants will be announced in January 2019. 

  • Funded projects will be required to demonstrate evidence of working in collaborations with other grantees, networks and institutions in Africa with drug discovery capacities, and to have mentors and/or collaborating institutions based in Africa or in the global South and North. 

  • Full details about the call for proposals is available on the Alliance for Accelerating Excellence in Science in Africa (AESA) website
  • Any queries regarding the call for proposals should be sent to: GCAfrica [at]